Delivery Order SPE2DB22D9304-SPE2DB24FSSW4
Award Date
6/14/24
Potential Completion Date
7/9/24
Potential Value
$11K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order valued at $3,868.50 under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) for the SPE2DB pharmaceutical Prime Vendor program. The contract is for the delivery of Xolair 150 mg/mL syringes, a specialty pharmaceutical product, to fulfill the recurring medical supply needs of military health facilities worldwide. As a prime vendor, DMS...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $6,963.30 firm fixed-price delivery order is for the pharmaceutical product Xolair 150 mg/mL syringe. This award is part of DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract (IDC) with the DLA to provide a wide range of pharmaceutical items, including both common and specialized medications, to support...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $7,737 firm fixed-price delivery order covers the supply of Xolair 150 mg/mL syringes to support the recurring medical needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order under the DLA's SPE2DB Prime Vendor program. The contract, valued at $4,642.20, is for the delivery of the pharmaceutical product Xolair 150 mg/mL syringe to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of medications,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $23,211 firm fixed-price contract is for the supply of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group is a key supplier of pharmaceutical products and medical supplies to the Department of Defense (DoD) and Department of Veterans...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $10,273.38 firm fixed-price delivery order is for the supply of Xolair 300 mg/2 ml syringes. DMS Pharmaceutical Group holds a single-award indefinite delivery contract (IDC) with the DLA, valued up to $499,999,999, which allows the agency to place orders for a comprehensive range of pharmaceutical items to support the medical...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $1,547.40 firm fixed-price delivery order is for the supply of XOLAIR 150 MG/ML SYRINGEML, a specialized pharmaceutical product, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the SPE2DB program. The $9,284.40 firm fixed-price delivery order is for the supply of Xolair (omalizumab) 150 mg/mL syringes to support the recurring medical needs of military health facilities. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB indefinite delivery contract valued at up to $499,999,999. The contract is for the delivery of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical supplies, to support the recurring medical needs of military healthcare facilities worldwide. The specific product...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order under the Defense Logistics Agency's (DLA) SPE2DB program. The $4,642.20 firm-fixed-price contract is for the supply of 4,563,044,599 units of the medication Xolair 150 mg/ml syringe. The award has no set-aside designation. DMS Pharmaceutical Group holds a $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the...